Hospital de Clínicas de Porto Alegre
Southern Brazil's leading public university hospital, known for cancer genetics, Li-Fraumeni research and one of Brazil's strongest clinical research programmes.
Hospital de Clínicas de Porto Alegre opened in 1971 as the teaching hospital of the Universidade Federal do Rio Grande do Sul and is one of Brazil's top public research hospitals and a designated high-complexity oncology centre. Its oncology and medical genetics services, under Patricia Ashton-Prolla and colleagues, characterised the high prevalence of the TP53 R337H founder mutation in southern Brazil and built hereditary cancer clinics and registries, and its haematology, paediatric oncology, breast and gastrointestinal cancer programmes contribute to Latin American and international cooperative trials, including through the Latin American Cooperative Oncology Group (LACOG) headquartered in Porto Alegre. HCPA runs a large clinical research centre and a radiotherapy and bone marrow transplant service for the public system.
- Hereditary cancer and Li-Fraumeni research
- Clinical research centre
- Haematology and transplant
- LACOG collaboration
Pages like this
not linked directly; found by shared links- InstitutionA.C. Camargo Cancer Center
Shares Li-Fraumeni syndrome (germline TP53), Hereditary cancer syndromes, Germline (hereditary) testing, TP53.
- InstitutionUniversity of Malaya Medical Centre
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- IdeaUse a polygenic risk score to set when screening starts
Shares Germline (hereditary) testing, Prostate cancer, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionInstituto Português de Oncologia do Porto Francisco Gentil
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, Prostate cancer, HR-positive / HER2-negative breast cancer.
- PersonLeif W. Ellisen
Shares BRCA1 / BRCA2 (HRD), TP53, HR-positive / HER2-negative breast cancer.
- InstitutionLagos University Teaching Hospital
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, Prostate cancer, HR-positive / HER2-negative breast cancer.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.